CONTEXT AND OBJECTIVE: Despite the high prevalence of vitamin D supplementation, its use remains controversial. outcomes assessed under various conditions, the current quality of evidence is low or unknown, and therefore insufficient for any recommendation. CONCLUSION: Based on moderate to high quality of evidence, the Cochrane systematic reviews included here showed that there were some benefits from vitamin D supplementation for pregnant women and asthma patients and no benefits for preventing fractures.
INTRODUCTION
A series of national surveys in the United States 1 have shown that vitamin supplementation is done most commonly in relation to vitamin D. These analyses, relating to 2011-2012, showed that the prevalence of vitamin D supplementation was around 40%. After excluding supplementation using multivitamin or multimineral sources, the frequency of vitamin D supplementation was still high (approximately 19%). 2 In addition, use of vitamin D supplementation has been increasing over the years. Supplementation with this micronutrient (excluding multivitamin/ multimineral sources) was around 5.1% in 1999-2000 (with a difference of 14 percentage points from the 2011-2012 prevalence). 2, 3 The intake of high-dose vitamin D supplements (more than 1000 IU/day) has also increased. In 1999-2000, a prevalence of 0.3% was reported, versus 15.8% in 2011-2012. 4 The number of published papers relating to vitamin D has also increased over time. A quick search in MEDLINE (via PubMed), using the strategy ("Vitamin D" [Mesh] ) and a broad filter of clinical trials, retrieved 192 references in 2016, versus 75 in 1996 (a mean of 150 references per year was found over the period considered). Despite the popularity of vitamin D use and the high number of studies on this topic, the efficacy and safety of its supplementation are still a matter for debate in the literature. 5 Because of the variety of dosages and formulations for vitamin D supplements and significant clinical heterogeneity between the conditions under which vitamin D is hypothesized to have benefits, the conclusions are still confusing.
Therefore, considering (a) the vast use of vitamin D supplementation, (b) the high number of primary studies published and (c) the controversy that continues in the literature, a systematic synthesis of the available evidence, such as the present review, is essential.
OBJECTIVE
To identify and summarize the evidence from Cochrane systematic reviews regarding vitamin D supplementation for preventing or treating any clinical condition.
METHODS

Design and setting
A review of Cochrane systematic reviews was conducted within the Discipline of Evidence-based Medicine of Escola Paulista de Medicina, Universidade Federal de São Paulo (EPM-Unifesp). This article was specifically developed for the section Cochrane Highlights, which is an initiative for disseminating Cochrane reviews. This initiative results from a formal partnership between the São Paulo Medical Journal and Cochrane, and it is supported by Cochrane Brazil.
Inclusion criteria
Types of study
We included any completed Cochrane systematic reviews published in the Cochrane Database of Systematic Reviews (CDSR).
Protocols of systematic reviews and withdrawn or outdated versions of systematic reviews were not included. There was no limitation regarding date of publication.
Types of participants
Healthy individuals or those diagnosed with any clinical condition were included, regardless of age, ethnicity or sex.
Types of intervention
We considered systematic reviews on vitamin D supplementation, in any form (active or non-active), presentation (capsules or oral solution), dose (high, conventional or underdoses), regimen or duration of use, as a single or combined intervention. We did not consider reviews in which the clinical question involved vitamin D in combination with other interventions and in which it was not possible to assess the effect of vitamin D in isolation.
Types of outcomes
We considered any clinical or laboratory outcomes evaluated by the authors of the systematic reviews.
Search for reviews
We conducted a systematic search in the Cochrane Database of Systematic Reviews (CDSR) (via Wiley) on April 4, 2017, sensitively using the MeSH term "Vitamin D" in titles, abstracts and keywords.
Selection of reviews
The titles and abstracts were read by two out of three authors (MVM, RLP or DVP) independently. The systematic reviews that met the inclusion criteria was selected. Any disagreement was solved by consulting a further author (RR or COCL).
Presentation of results
The results from the search and the systematic reviews included were presented through a descriptive structure (qualitative synthesis).
RESULTS
Search results
Our search strategy retrieved 53 references and, after screening the titles and abstracts, 28 systematic reviews were preselected.
After assessing full texts, 27 reviews 6-32 were found to fulfill our inclusion criteria and were included for qualitative analysis.
One systematic review that assessed vitamin D plus calcium supplementation for treating corticosteroid-induced osteoporosis was excluded because it was not possible to evaluated the effect of vitamin D in isolation.
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Reviews included
A summary of the issues, objectives, main findings and quality of evidence among the 27 systematic reviews included is presented below. We also present a brief individual summary of each review included, according to the clinical situation. For detailed explanations, the full versions can be viewed in the box in Table 1 . 34 1. Asthma
The review 6 No differences in total body bone mineral content, hip bone mineral density, lumbar spine bone mineral density or forearm bone mineral density.
- 
Atopic eczema
The review 
Sickle cell disease
Sickle cell disease is associated with multiple micronutrient defi- 
Multiple sclerosis
The review 9 evaluated the effects of vitamin D for multiple sclerosis and included only one small RCT (n = 49; 52-week follow-up), which 
Postmenopausal women and older men
The purpose of the review 11 was to determine the effects of vitamin D or related compounds for preventing fractures among postmenopausal women and older men. This review included 53
RCTs (n = 91,791) and the results showed that vitamin D alone was not effective for preventing:
• Hip fracture (RR 1.12; 95% CI 0.98 to 1.29; 11 RCTs; n = 27,693);
• Any new fracture (RR 1.03; 95% CI 0.96 to 1.11; 15 RCTs; n = 28,271).
The authors concluded that with the current evidence, vitamin D alone was unlikely to prevent fractures.
For further details, refer to the original abstract, available at: http:// onlinelibrary.wiley.com/doi/10.1002/14651858.CD000227.pub4/full.
Prevention of adverse outcomes in pregnancy
The aim of the systematic review 12 was to assess the effects of oral supplementation with vitamin D during pregnancy for improving maternal and neonatal outcomes. The review included 15 RCTs (n = 2,833) and it showed that vitamin D supplementation during pregnancy provided benefits regarding the following outcomes:
• Risk of preterm birth (RR 0.36; 95% CI 0.14 to 0.93; three RCTs; n = 477; moderate-quality evidence);
• Risk of low birthweight (RR 0.40; 95% CI 0.24 to 0.67; three RCTs; n = 493; moderate-quality evidence). 
Chronic painful conditions in adults
The review 13 
Prevention of cancer in adults
The aim of the review 14 was to assess the effectiveness and safety of vitamin D (cholecalciferol, ergocalciferol, alfacalcidol and calcitriol) for preventing cancer, and included 18 RCTs (n = 50,623).
The following results were found:
• Risk of cancer: no significant reduction through vitamin D supplementation over a follow-up of 0.5 to seven years (RR 1.00; 95%
CI 0.94 to 1.06; 18 RCTs; n = 50,623; moderate-quality evidence);
• All-cause mortality: through vitamin D supplementation over a follow-up of 0.5 to 7 years (RR 0.93; 95% CI 0.88 to 0.98; 15 RCTs; n = 49,866; low-quality evidence);
• Cancer-related mortality: no significant reduction through cholecalciferol (RR 0.88; 95% CI 0.78 to 0.98; four RCTs; n = 44,492; low-quality evidence).
This review did not show any evidence of effects from any presentation of vitamin D in relation to reducing the risk of cancer.
It was found that there was a general need for more studies in order to make any recommendations regarding clinical practice.
For further details, refer to the original abstract, available at: http:// onlinelibrary.wiley.com/doi/10.1002/14651858.CD007469.pub2/full.
Cystic fibrosis
The review 15 
Prevention of mortality among adults
The objective of the review 16 • Cancer-related mortality; reduction of 12% (RR 0.88; 95% CI 0.79 to 0.98; four RCTs; n = 44,492; moderate-quality evidence).
For the comparisons of cholecalciferol plus calcium versus placebo or no treatment, the risk of nephrolithiasis was higher in the treated group (RR 1.07; 95% CI 1.02 to 1.34; four RCTs; n = 42,876). The risk of attrition bias due to the substantial dropout of participants and the risk of outcome reporting bias regarding mortality weakened the current evidence. Further RCTs with strong methodological and reporting quality would be needed in order to draw any practical conclusion.
For further details, refer to the original abstract, available at: http://onlinelibrary.wiley.com/doi/10.1002/14651858.
CD007470.pub3/full.
Recovery from hip fracture among elderly people
The aim of the review 17 CD001880.pub6/full.
Latent autoimmune diabetes (LADA) in adults
The review 18 CD006165.pub3/full.
Sexual dysfunction among patients with chronic kidney disease (CKD)
The purpose of the review 19 CD007747.pub2/full.
Cases of chronic kidney disease (CKD) not requiring dialysis
The objective of the review 20 was to evaluate the efficacy of vitamin D for patients with CKD who were not requiring dialysis.
Sixteen RCTs (n = 894) were included. Some analyses showed lower serum parathyroid hormone (PTH) concentration and higher calcium and phosphorus concentration, but no benefits in relation to primary clinical outcomes, such as mortality or risk of dialysis, were found. The authors concluded that there were insufficient data to determine the effect of vitamin D on mortality and relevant clinical outcomes among chronic non-dialytic renal patients.
For further details, refer to the original abstract, available at:
http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD008175/full.
Cases of chronic kidney disease (CKD) requiring dialysis
The review 21 CD005633.pub2/full.
Metabolic bone disease in children with chronic kidney disease (CKD)
The purpose of the review 22 
Kidney transplant recipients
The aim of the review 23 CD005015.pub3/full.
Autosomal dominant polycystic kidney disease (ADPKD)
The review 24 evaluated the effects of interventions for preventing progression of ADPKD, in relation to kidney function, kidney endpoints, kidney structure, patient-centered endpoints and the adverse effects of these treatments. This review included 30 studies, but only one RCT (n = 34) evaluated vitamin D supplementation, which was done in comparison with Chinese medicine (herbs). The data were sparse and inconclusive, and the authors were unable to make any solid recommendations.
CD010294.pub2/full.
Prevention of bone outcomes in healthy children
The aim of the review 25 CD006944.pub2/full.
Prevention of nutritional rickets in term-born children
The review 26 aimed to evaluate the effects of any intervention for prevention of rickets in term-born children. It included three RCTs and one non-randomized clinical trials (n = 1,700).
Only three studies evaluated use of vitamin D alone, but in two of these studies there were no occurrences of rickets in either group.
One study comparing vitamin D (400 IU per day for 12 months) versus no intervention showed that there was a statistical reduction in the risk of occurrence of rickets (RR 0.04; 95% CI 0 to 0.71; one RCT; n = 676). Even in the light of this result, the authors considered it reasonable to offer vitamin D or calcium for prevention of rickets to all children up to two years of age.
However, they pointed out that further studies would be needed to investigate the effects in higher-risk subgroups and to investigate possible adverse effects.
This recommendation needs to be better evaluated, considering that 1. Only one study contributed towards this conclusion; 
Prevention of infections in children under five years of age
The purpose of the review 27 was to evaluate the role of vitamin D supplementation in preventing infections in children under five years of age. Four RCTs (n = 3,198) were included. No difference between the vitamin D and control groups (placebo or no supplementation) was found in relation to the following outcomes:
• All-cause mortality (mortality due to any cause of death) (RR 1.43; 95% CI 0.54 to 3.74; one RCT; n = 3,046; low-quality evidence);
• Cause-specific mortality (mortality due to pneumonia, tuberculosis, diarrhea or malaria) (RR 1.50; 95% CI 0.42 to 5.30; one RCT; n = 3,046; low-quality evidence);
• Risk of a radiologically confirmed first or only episode of pneumonia (RR 1.06; 95% CI 0.89 to 1.26; two RCTs; n = 3,134;
moderate-quality evidence);
• Risk of diarrhea (two RCTs; no numerical data provided).
No study investigating other infectious diseases such as tuberculosis or malaria was found. The authors concluded that the implications of this systematic review were limited because of the low availability of primary studies.
For further details, refer to the original abstract, available from: http:// onlinelibrary.wiley.com/doi/10.1002/14651858.CD008824.pub2/full.
Children and adults with HIV infection
The review 28 aimed to evaluate the efficacy and safety of micronutrient supplementation for reduction of morbidity and mortality among adults and children with HIV infection. Thirty-three RCTs were included, but only five (n = 447) were on vitamin D (alone or in combination with calcium). The results showed that vitamin D did not provide any benefit in relation to the following outcomes:
• Mortality among HIV patients with active tuberculosis (RR 1.15; 95% CI 0.65 to 2.02; one RCT; n = 131; very low-quality evidence);
• CD4 cell count (data from four RCTs, not pooled; n = 288).
The authors concluded that further larger RCTs, with strong methodological quality, using individual supplementation of vitamin D would be needed in order to build a baseline of evidence.
For further details, refer to the original abstract, available at: http:// onlinelibrary.wiley.com/doi/10.1002/14651858.CD003650.pub4/full.
Active tuberculosis
The objective of the review 29 
Prevention of falls among stroke victims
Falls are a common complication after stroke. Around 7% of stroke victims suffer falls in the first week after stroke onset. 
Prevention of falls among elderly people living in the community
The review 32 
DISCUSSION
This study included 27 Cochrane systematic reviews: 10 related to prevention and 17 assessed use of vitamin D as a therapeutic option. Among the preventive systematic reviews, five focused on healthy individuals for prevention of death, 16 cancer, 14 and other adverse outcomes. 12, 25, 27 Despite the considerable number of Cochrane reviews, eight of them did not present any reliable evidence regarding benefits or harm from vitamin D, including reviews on clinical situations in which use of vitamin D is frequently observed in clinical practice, such as in relation to multiple sclerosis 9 and atopic eczema. 7 Thus, in those reviews, the authors were unable to provide recommendations regarding the benefits and risks of vitamin D. A second point that deserves discussion is that many of the reviews included were planned, conducted or published some years ago, and therefore were based on early versions of the Cochrane Handbook, which were less detailed and complex than the current version (http:// training.cochrane.org/handbook). As an example, the inclusion criteria and methods for assessing the quality of clinical trials were not refined as they are now. Moreover, Grading of Recommendations Assessment, Development and Evaluation (GRADE) is a new approach that was not yet mandatory for Cochrane reviews. Implementation of the Cochrane Risk of Bias Table, and mandatory use of GRADE and Methodological Expectations of Cochrane Intervention Reviews (MECIR) have contributed towards improving the methodological rigor of Cochrane reviews over the years. Therefore, it is reasonable to assume that older reviews may not present the same quality as recent reviews, which could limit the applicability of findings.
Regarding the implications of these Cochrane reviews for clinical practice, moderate to high-quality evidence of benefit from vitamin D for pregnant women (prevention of maternal and child adverse outcomes) and for asthma patients (reduction of severe exacerbations) was found. Additionally, no benefit from vitamin D supplementation alone (without calcium) for preventing hip fracture or any new fracture was found. For all other benefits or harm, the current quality of evidence was low or unknown, and therefore insufficient for any recommendations.
Regarding the implications of this study for further research, 
CONCLUSION
This study identified 27 Cochrane reviews that provided evidence of quality ranging from unknown to high, in relation to vitamin D supplementation as preventive or therapeutic intervention. Vitamin D was found to present some benefit for pregnant women and asthma patients and no benefit when administered alone (without calcium) for preventing fractures. For all other likely benefit or harm that has been evaluated through Cochrane reviews, the current quality of evidence is low or unknown, and therefore insufficient for any sound conclusion.
